⌘K
Vertex Ventures HC logo

Vertex Ventures HC

Crunchbase
Crunchbase

Deals on record

2

Common Fundraising Type

Series A

Indapta Therapeutics logo
Indapta Therapeutics

Biotechnology • Clinical-stage

Vertex Ventures HC logo
RA Capital Management logo
Pontifax logo
Myeloma Investment Fund logo

Indapta Therapeutics develops allogeneic Natural Killer (NK) cell therapies for treating cancer and autoimmune diseases.

Equity
$22.5M
12/17/2024
Article
EyeBio logo
EyeBio

Ophthalmology Biotechnology • Clinical-Stage

Vertex Ventures HC logo
Omega Funds logo
SV Health Investors logo
Samsara Biocapital logo

EyeBio is a clinical-stage ophthalmology biotechnology company focused on developing therapies for sight-threatening eye diseases and has expanded its Series A funding to $130 million.

Series A
$65M
11/14/2023
Article